Protection against murine endotoxemia by treatment with Ruta Chalepensis L., a plant with anti-inflammatory properties

Journal of Ethnopharmacology

Volumn 90, Issue 2-3, 2004, Pages 267-272

  Iauk, Liliana ^a   Mangano, Katia ^a   Rapisarda, Antonio ^b   Ragusa, Salvatore ^b   Maiolino, Luigi ^a   Musumeci, Rosario ^a   Costanzo, Rosaria ^a   Serra, Agostino ^a   Speciale, Annamaria ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Anti inflammatory properties; Endotoxemia; Ruta chalepensis

Indexed keywords

ANTIINFLAMMATORY AGENT; BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 10; INTERLEUKIN 6; NITRITE; RUTA CHALEPENSIS EXTRACT; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; FEEDING; FEMALE; IMMUNOPHARMACOLOGY; LETHALITY; NONHUMAN; PROPHYLAXIS; PROTEIN BLOOD LEVEL; RUTA CHALEPENSIS; RUTACEAE;

RUTA CHALEPENSIS;

EID: 0842263793     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2003.10.004     Document Type: Article

References (35)

1. Abraham E. Why immunomodulatory therapies have not worked in sepsis? Intensive Care Medicine. 25:1999;556-566.
2. Alexander H.R., Doherty G.M., Buresh C.M., Venzon D.J., Norton J.A. A recombinant human receptor antagonist to interleukin-1 improves survival after lethal endotoxemia in mice. Journal of Experimental Medicine. 173:1991;1029-1032.
3. Ashkenazi A., Marsters S.A., Capon D.J., Chamow S.M., Figari I.S.et al. Protection against endotoxin shock by tumour necrosis factor receptor immunoadhesion. Proceedings of the National Academy of Sciences. 88:1991;10535-10539.
4. Atta A.H., Alkofahi A. Anti-nociceptive and anti-inflammatory effects of some Jordanian medicinal plants extracts. Journal of Ethnopharmacology. 28:1998;306-311.
5. Baumhofer J.M., Beinhauer B.G., Wang J.E., Brandmeier H., Geissler K.et al. Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophage immune competence. European Journal of Immunology. 28:1998;610-615.
6. Bendtzen K. Interleukin-1, interleukin-6 and tumour necrosis factor in infection, inflammation and immunity. Immunology Letters. 19:1988;183-192.
7. Dalrymple S.A., Slattery R., Aud D.M., Krishna M., Lucian L.A., Murray R. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infection and Immunity. 64:1996;3231-3235.
8. De Angelo J. Nitric oxide scavangers in the treatment of septic shock associated with systemic inflammatory response syndrome. Expert Opinion on Pharmacotherapy. 1:1999;19-29.
9. Di Stasi L.C., Hiruma C.A., Guimaraes C.M. Medicinal plants used in Brazilian Amazon. Fitoterapia. 65:1994;529-540.
10. Durez P., Appelboom T., Pira C., Stordeur P., Vray B., Goldman M. Anti-inflammatory properties of mycophenate mofetil in murine endotoxemia: inhibition of TNF-alpha and up-regulation of IL-10 release. International Journal of Immunopharmacology. 21:1999;581-587.
11. Font Quer, P., 1962. Plantas Medicinales. Labor, p. 426.
12. Gèrard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P. Interleukin-10 reduces the release of tumour necrosis factor and prevents lethality in experimental endotoxemia. Journal of Experimental Medicine. 177:1993;547-550.
13. Glauser M.P., Zanetti G., Baumgartner J.D., Cohen J. Septic Shock: Pathogenesis. 338:1991;732-736.
14. Gold D.P., Schroder K., Powell H.C., Kelly C.J. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. European Journal of Immunology. 27:1997;2863-2869.
15. Heinzel F.P. The role of IFN-γ in the pathology of experimental endotoxemia. Journal of Immunolology. 145:1990;2920-2924.
16. Hollenberg S.M., Broussard M., Osman J., Parrillo J.E. Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circulation Research. 86:2000;774-778.
17. Hnatyszyn O., Arenas P., Moreno A.R., Rondina R., Coussio J.D. Plantas reguladoras de la fecundidad segun la medicina folklòrica. Revista de la Sociedad Cientifica. 14:1974;37.
18. Iskit A.B., Guc M.O. The timing of endothelin and nitric oxide inhibition affects survival in a mice model of septic shock. European Journal of Pharmacology. 414:2001;281-287.
19. MacMicking J.K., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.W., Sokol K., Hutchinson N.et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 19:1995;641-650.
20. Mansour S. Al-Said, Tariq M., Al-Yahya M.A., Rafatullah S., Ginnawi O.T., Ageel A.M. Studies on Ruta chalepensis, an ancient medicinal herb still used in traditional medicine. Journal of Ethnopharmacology. 28:1990;305-312.
21. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacological Reviews. 43:1991;109-142.
22. Muchamuel T., Menon S., Pisacane P., Howard M.C.et al. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-α, IFN-γ and IL-12 production. Journal of Immunology. 158:1997;2898-2903.
23. Nicoletti F., Zaccone P., Di Marco R., Magro G., Grasso S., Morrone S., Santoni A., Tempera G., Meroni P.L., Bendtzen K. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock. Immunology. 85:1995;645-650.
24. Nicoletti F., Mancuso V., Cusumano R., Di Marco R., Zaccone P. Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13. European Journal Immunology. 27:1997a;1580-1583.
25. Nicoletti F., Mancuso G., Anzani-Ciliberti F., Beninanti C., Carbone M. et al. Endotoxin-induced lethality in mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10. Clinical and Diagnostic Laboratory Immunology. 4:1997b;607-610.
26. Nicoletti F., Di Marco R., Sacerdote P., Meroni P.L., Mangano K. Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP14. Antimicrobial Agents and Chemotherapy. 45:2001;1591-1594.
27. Ohlsson K., Bjork P., Bergenfeldt M., Hageman R., Thompson R.C. Interleukin-1 receptor antagonist reduces mortality from septic shock. Nature. 348:1990;550-552.
28. Pignatti, S., 1982. Flora d'Italia, vol. 2. Edagricole, p. 52.
29. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes-Metabolism Reviews. 14:1998;129-151.
30. Rasmussen A.K., Di Marco R., Diamant M., Feldt-Rasmussen U., Bendtzen K. Nitric oxide production is not involved in the effects of interleukin-1β on cAMP, thyroglobulin and interleukin-6 in TSH-stimulated human thyroid cells. Autoimmunity. 19:1994;239-245.
31. Tarazona R., Gonzàlez-Garcìa A., Zamzani N., Marchetti P., Frechin N. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. Journal of Immunology. 154:1995;861-870.
32. Ullrich R., Scherrer-Crosbie M., Block K.D., Ichinose F., Nakajima H. Congential deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation. 102:2000;1440-1446.
33. Ulubelen A., Terem B., Tuzlaci E., Cheng K.F., Kong Y.C. Alkaloids and coumarins from Ruta chalepensis. Phytochemistry. 25:1986;2692-2693.
34. Vermeire K., Thielemans L., Matthys P., Billiau A. The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-gamma. Journal of Leukocyte Biology. 68:2000;119-124.
35. Weinberg J.B., Granger D.L., Pisetsky D.S., Seldin M.F., Misukonis M.A. et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and resolution of spontaneous glomerulonephritis and arthritis by orally-administered NG-monomethyl-L- arginine. Journal of Experimental Medicine. 179:1994;651-660.